32.jpg)
56.jpg)
1:00 pm
Investors Club
SymBiontics Developments
Pitch
Biotech & Therapeutics
Spin-off developing a novel colorectal cancer therapy targeting resistance mechanisms, combined with a patient-selection biomarker and licensed to pharma.
Speakers
Related activities
Back to agenda